Correlation Between Talaris Therapeutics and IGM Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Talaris Therapeutics and IGM Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talaris Therapeutics and IGM Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Talaris Therapeutics and IGM Biosciences, you can compare the effects of market volatilities on Talaris Therapeutics and IGM Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talaris Therapeutics with a short position of IGM Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talaris Therapeutics and IGM Biosciences.

Diversification Opportunities for Talaris Therapeutics and IGM Biosciences

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Talaris and IGM is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Talaris Therapeutics and IGM Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IGM Biosciences and Talaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talaris Therapeutics are associated (or correlated) with IGM Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IGM Biosciences has no effect on the direction of Talaris Therapeutics i.e., Talaris Therapeutics and IGM Biosciences go up and down completely randomly.

Pair Corralation between Talaris Therapeutics and IGM Biosciences

If you would invest  298.00  in Talaris Therapeutics on August 28, 2024 and sell it today you would earn a total of  0.00  from holding Talaris Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Talaris Therapeutics  vs.  IGM Biosciences

 Performance 
       Timeline  
Talaris Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Talaris Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Talaris Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
IGM Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in IGM Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating primary indicators, IGM Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Talaris Therapeutics and IGM Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Talaris Therapeutics and IGM Biosciences

The main advantage of trading using opposite Talaris Therapeutics and IGM Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talaris Therapeutics position performs unexpectedly, IGM Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IGM Biosciences will offset losses from the drop in IGM Biosciences' long position.
The idea behind Talaris Therapeutics and IGM Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios